Diagnosis in oncology. Neoadjuvant (induction) erlotinib response in stage IIIA non--small-cell lung cancer.

Autor: Kappers I, Klomp HM, Burgers JA, Van Zandwijk N, Haas RLM, van Pel R
Zdroj: Journal of Clinical Oncology; 9/1/2008, Vol. 26 Issue 25, p4205-4207, 3p
Databáze: Supplemental Index